Christopher Causey Insider Trading Activity
Christopher Causey has been net-selling over the last 12 months with 0 purchases and 7 sales across 1 company.
UTHR is the most-traded position with 7 trades. The largest single transaction was a sale of UTHR for $786K on Mar 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Christopher Causey. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +0.2% | 57% | 7 |
| 90 days | — | -9.2% | 14% | 7 |
| 120 days | — | -12.4% | 0% | 6 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersUTHR · UNITED THERAPEUTICS Corp
🔒 Subscribe to see trade entries
Pro members see exactly when Christopher Causey bought and sold UTHR.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 30, 2026 | UTHR | Sell | 1,300 | $604.64 | $786K | −23.7% | Director | |
Mar 4, 2026 | UTHR | Sell | 20 | $490.17 | $10K | −0.5% | Director | |
Feb 25, 2026 | UTHR | Sell | 1,000 | $520.00 | $520K | −19.3% | Director | |
Jan 6, 2026 | UTHR | Sell | 1,000 | $510.00 | $510K | −19.3% | Director | |
Jan 2, 2026 | UTHR | Sell | 1,000 | $500.01 | $500K | −19.3% | Director | |
Sep 24, 2025 | UTHR | Sell | 1,000 | $440.00 | $440K | −17.1% | Director | |
Sep 2, 2025 | UTHR | Sell | 1,000 | $419.63 | $420K | −12.7% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 7 | $3.2M |
Other insiders at UNITED THERAPEUTICS Corp
9 other tracked filers at UTHR.